Time from Positive Screening Fecal Occult Blood Test to Colonoscopy and Risk of Neoplasia

被引:30
作者
Gellad, Ziad F. [1 ,2 ]
Almirall, Daniel [2 ,3 ]
Provenzale, Dawn [1 ,2 ]
Fisher, Deborah A. [1 ,2 ]
机构
[1] Duke Univ, Med Ctr, Div Gastroenterol, Dept Med, Durham, NC 27710 USA
[2] Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA
[3] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA
关键词
Colonic neoplasm; Occult blood; Colonoscopy; Follow-up studies; COLORECTAL-CANCER; DIAGNOSIS; SURVIVAL;
D O I
10.1007/s10620-008-0653-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
There is no guideline defining the optimal time from a positive screening fecal occult blood test to follow-up colonoscopy. We reviewed records of 231 consecutive primary care patients who received a colonoscopy within 18 months of a positive fecal occult blood test. We examined the relationship between time to colonoscopy and risk of neoplasia on colonoscopy using a logistic regression analysis adjusting for potential confounders such as age, race, and gender. The mean time to colonoscopy was 236 days. Longer time to colonoscopy (OR = 1.10, P = 0.01) and older age (OR 1.04, P = 0.01) were associated with higher odds of neoplasia. The association of time with advanced neoplasia was positive, but not statistically significant (OR 1.07, P = 0.14). In this study, a longer interval to colonoscopy after fecal occult blood test was associated with an increased risk of neoplasia. Determining the optimal interval for follow-up is desirable and will require larger studies.
引用
收藏
页码:2497 / 2502
页数:6
相关论文
共 23 条
[1]   Does high body fatness increase the risk of presence and growth of colorectal adenomas followed up in situ for 3 years? [J].
Almendingen, K ;
Hofstad, B ;
Vatn, MH .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (07) :2238-2246
[2]  
[Anonymous], 2004, Applied logistic regression
[3]   The place of fecal occult blood test in colorectal cancer screening in 2006: The US perspective [J].
Bond, JH .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (02) :219-221
[4]  
DAIGH JD, 2006, HEALTHCARE INSPECTIO
[5]   SCREENING FOR COLORECTAL-CANCER [J].
EDDY, DM .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (05) :373-384
[6]   Symptom-to-diagnosis interval and survival in cancers of the digestive tract [J].
Fernandez, E ;
Porta, M ;
Malats, R ;
Belloc, J ;
Gallén, M .
DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (11) :2434-2440
[7]   Barriers to full colon evaluation for a positive fecal occult blood test [J].
Fisher, Deborah A. ;
Jeffreys, Amy ;
Coffman, Cynthia J. ;
Fasanella, Kenneth .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (06) :1232-1235
[8]   Randomised controlled trial of faecal-occult-blood screening for colorectal cancer [J].
Hardcastle, JD ;
Chamberlain, JO ;
Robinson, MHE ;
Moss, SM ;
Amar, SS ;
Balfour, TW ;
James, PD ;
Mangham, CM .
LANCET, 1996, 348 (9040) :1472-1477
[9]   Molecular heterogeneity of colorectal cancer: Implications for cancer control [J].
Jass, Jeremy R. .
SURGICAL ONCOLOGY-OXFORD, 2007, 16 :S7-S9
[10]   Emerging concepts in colorectal neoplasia [J].
Jass, JR ;
Whitehall, VLJ ;
Young, J ;
Leggett, BA .
GASTROENTEROLOGY, 2002, 123 (03) :862-876